BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38637882)

  • 1. Genetic diagnosis of endocrine disorders in Cyprus through the Cyprus Institute of Neurology and Genetics: an ENDO-ERN Reference Center.
    Neocleous V; Fanis P; Toumba M; Skordis N; Phylactou LA
    Orphanet J Rare Dis; 2024 Apr; 19(1):167. PubMed ID: 38637882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GnRH Deficient Patients With Congenital Hypogonadotropic Hypogonadism: Novel Genetic Findings in
    Neocleous V; Fanis P; Toumba M; Tanteles GA; Schiza M; Cinarli F; Nicolaides NC; Oulas A; Spyrou GM; Mantzoros CS; Vlachakis D; Skordis N; Phylactou LA
    Front Endocrinol (Lausanne); 2020; 11():626. PubMed ID: 32982993
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic testing in inherited endocrine disorders: joint position paper of the European reference network on rare endocrine conditions (Endo-ERN).
    Eggermann T; Elbracht M; Kurth I; Juul A; Johannsen TH; Netchine I; Mastorakos G; Johannsson G; Musholt TJ; Zenker M; Prawitt D; Pereira AM; Hiort O;
    Orphanet J Rare Dis; 2020 Jun; 15(1):144. PubMed ID: 32513286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of genetic defects in endocrinopathies in the island of Cyprus; evidence of a founder effect.
    Shammas C; Neocleous V; Toumba M; Costi C; Phedonos AA; Efstathiou E; Kyriakou A; Phylactou LA; Skordis N
    Genet Test Mol Biomarkers; 2012 Sep; 16(9):1073-9. PubMed ID: 22857144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple endocrine neoplasia 2 in Cyprus: evidence for a founder effect.
    Fanis P; Skordis N; Frangos S; Christopoulos G; Spanou-Aristidou E; Andreou E; Manoli P; Mavrommatis M; Nicolaou S; Kleanthous M; Cariolou MA; Christophidou-Anastasiadou V; Tanteles GA; Phylactou LA; Neocleous V
    J Endocrinol Invest; 2018 Oct; 41(10):1149-1157. PubMed ID: 29396759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted gene panel sequencing for molecular diagnosis of congenital adrenal hyperplasia.
    Wang W; Han R; Yang Z; Zheng S; Li H; Wan Z; Qi Y; Sun S; Ye L; Ning G
    J Steroid Biochem Mol Biol; 2021 Jul; 211():105899. PubMed ID: 33864926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High carrier frequency of 21-hydroxylase deficiency in Cyprus.
    Phedonos AA; Shammas C; Skordis N; Kyriakides TC; Neocleous V; Phylactou LA
    Clin Genet; 2013 Dec; 84(6):585-8. PubMed ID: 23600966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene.
    Concolino P; Costella A
    Mol Diagn Ther; 2018 Jun; 22(3):261-280. PubMed ID: 29450859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Spectrum of Genetic Defects in Congenital Adrenal Hyperplasia in the Population of Cyprus: A Retrospective Analysis.
    Neocleous V; Fanis P; Toumba M; Stylianou C; Picolos M; Andreou E; Kyriakou A; Iasonides M; Nicolaou S; Kyriakides TC; Tanteles GA; Skordis N; Phylactou LA
    Horm Metab Res; 2019 Sep; 51(9):586-594. PubMed ID: 31505704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis and genotype-phenotype correlations of congenital adrenal hyperplasia (CAH) in Anatolian population.
    Dundar A; Bayramov R; Onal MG; Akkus M; Dogan ME; Kenanoglu S; Cerrah Gunes M; Kazimli U; Ozbek MN; Ercan O; Yildirim R; Celmeli G; Parlak M; Dundar I; Hatipoglu N; Unluhizarci K; Akalin H; Ozkul Y; Saatci C; Dundar M
    Mol Biol Rep; 2019 Aug; 46(4):3677-3690. PubMed ID: 31006099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of Congenital Adrenal Hyperplasia Using Long-Read Sequencing.
    Liu Y; Chen M; Liu J; Mao A; Teng Y; Yan H; Zhu H; Li Z; Liang D; Wu L
    Clin Chem; 2022 Jul; 68(7):927-939. PubMed ID: 35714169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple virilising congenital adrenal hyperplasia in monozygotic twins: A rare report and review of previous cases.
    Muthuvel B; Gautam A; Pal R; Panigrahi I; Dayal D
    Pediatr Endocrinol Diabetes Metab; 2020; 26(1):58-62. PubMed ID: 32272826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing in multiple endocrine neoplasia and related syndromes.
    Calender A
    Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of congenital adrenal hyperplasia.
    Krone N; Arlt W
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):181-92. PubMed ID: 19500762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-existence of Congenital Adrenal Hyperplasia and Familial Hypokalemic Periodic Paralysis due to
    Çetin T; Turan İ
    J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):362-366. PubMed ID: 33389921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic screening of non-classic CAH females with hyperandrogenemia identifies a novel CYP11B1 gene mutation.
    Shammas C; Byrou S; Phelan MM; Toumba M; Stylianou C; Skordis N; Neocleous V; Phylactou LA
    Hormones (Athens); 2016 Apr; 15(2):235-242. PubMed ID: 27376426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic RET genetic testing in 1,058 index patients: A UK centre perspective.
    Fussey JM; Smith JA; Cleaver R; Bowles C; Ellard S; Vaidya B; Owens M
    Clin Endocrinol (Oxf); 2021 Aug; 95(2):295-302. PubMed ID: 33340421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and biochemical screening for endocrine disease.
    Goretzki PE; Höppner W; Dotzenrath C; Clark OH; Simon D; Cupisti K; Schulte H; Röher HD
    World J Surg; 1998 Dec; 22(12):1202-7. PubMed ID: 9841744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RET proto-oncogene mutations are restricted to codon 618 in Cypriot families with multiple endocrine neoplasia 2.
    Neocleous V; Skordis N; Portides G; Efstathiou E; Costi C; Ioannou N; Pantzaris M; Anastasiadou V; Deltas C; Phylactou LA
    J Endocrinol Invest; 2011 Nov; 34(10):764-9. PubMed ID: 21422799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
    Nesković G; Stanojević B; Palmar I; Dimitrijević B
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.